Close Window

Digital Look Email A Friend

GlaxoSmithKline receives FDA approval for new presentation of Menveo asset

Published by Iain Gilbert on 17th October 2022

(Sharecast News) - Drugmaker GlaxoSmithKline has received Food and Drug Administration approval for a new presentation of its invasive meningococcal disease vaccine.

URL: http://www.digitallook.com/dl/news/story/33036988/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.